DePuy Mitek FMS Outflow Tubing with One-Way valve Product Code:284649 Product Usage: The Int...

FDA Device Recall #Z-0192-2014 — Class II — August 29, 2013

Recall Summary

Recall Number Z-0192-2014
Classification Class II — Moderate risk
Date Initiated August 29, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm DePuy Mitek, Inc., a Johnson & Johnson Co.
Location Raynham, MA
Product Type Devices
Quantity 29280 units

Product Description

DePuy Mitek FMS Outflow Tubing with One-Way valve Product Code:284649 Product Usage: The Intermediary Tubing for FMS¿ Fluid Management Systems connects the Inflow Tubing to the arthroscopic sheath during arthroscopic procedures. The Polyvinyl Chloride (PVC) tubing integrates several functional components including: luer locks for attaching the tube to the Inflow tubing and sheath, clamps, and a one-way valve. The FMS Outflow Tubing with One-Way valve is sterile and intended for single use with the FMS Fluid Management Systems in a surgical setting by personnel trained in arthroscopy.

Reason for Recall

Pillow valve included in the FMS Duo outflow tubing set and the FMS Solo intermediary tubing set may not perform as intended. may result in backflow of irrigation fluid into the One Day Set which may potentially lead to patient cross-contamination

Distribution Pattern

Worldwide Distribution - USA (Nationwide) and in the countries of: Australia , Austria , Belgium , Canada , Czech Republic , Denmark , Finland , France, Germany , India, Ireland , Israel, Italy , Latvia , Netherlands , Norway , Nepal, Poland , Portugal , Spain , Sweden , Switzerland , United Kingdom.

Lot / Code Information

All lot codes

Other Recalls from DePuy Mitek, Inc., a Johnson & Johnso...

Recall # Classification Product Date
Z-1314-2025 Class II COR Disposable Kit, 8 mm. Cartilage Transplant ... Feb 24, 2025
Z-1315-2025 Class II COR Disposable Kit, 8 mm w/ Perpendicularity. C... Feb 24, 2025
Z-1678-2023 Class II DePuy Mitek BIOKNOTLESS Plus w/ Panacryl-Indica... Apr 13, 2023
Z-1679-2023 Class II DePuy Mitek BIOKNOTLESS Plus w/ OC-Indicated fo... Apr 13, 2023
Z-1680-2023 Class II DePuy Mitek BIOKNOTLESS Rapid W/ OC-Indicated f... Apr 13, 2023

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.